Dow Jones Makes Modest Gain After Previous Losses
The Dow Jones Industrial Average turned slightly higher in morning trade on Friday, recovering from a 1.3% intraday loss the previous day. Technology stocks in the Nasdaq composite also experienced…
The Dow Jones Industrial Average turned slightly higher in morning trade on Friday, recovering from a 1.3% intraday loss the previous day. Technology stocks in the Nasdaq composite also experienced…
NTPC, a power generation major, has garnered exceptional support from analysts, with 24 'Buy' calls and only 1 'Sell' call. This overwhelming positive sentiment is a rarity among PSU stocks.…
Sibanye-Stillwater Limited ADS, also known as SBSW, is a leading international precious metals mining company, with a diverse portfolio of platinum group metal (PGM) operations in the United States, South…
SoftBank's Vision Fund unit, responsible for investments in companies like Uber, WeWork, and DoorDash, has posted a gain of about $1.1 billion, marking its first gain in six quarters. This…
The blistering stock rally of 2023 is currently facing a potential threat, according to David Lebovitz, a global market strategist at JPMorgan Asset Management. Lebovitz pointed out that the recent…
Viant Technology Inc. (NASDAQ: DSP) held its Second Quarter 2023 Earnings Conference Call to discuss the company's performance. The call was led by Tim Vanderhook, Co-Founder and CEO of Viant…
In the world of generative AI, big players like Microsoft and OpenAI dominate the conversation around regulation. These companies have had a significant impact on shaping the terms of the…
Shares of Abbott Laboratories (ABT) experienced a decline of 2.65% to $105.58 during a challenging trading session in the stock market. The broader market also saw a drop, with the…
Skyworks Solutions, a leading semiconductor company, announced its financial results for the third quarter of fiscal 2023. Despite facing macro headwinds, the company delivered in line revenue with solid profitability…
In the last trading session, 1.18 million Inozyme Pharma Inc. (NASDAQ:INZY) shares were traded, with a beta of 0.97. The company's per share price was $4.81, reflecting a decrease of…